Guerbet appoints Yves L'Epine CEO
This article was originally published in Scrip
Executive Summary
Guerbet, a pharmaceutical group dedicated to medical imaging, has appointed Dr Yves L'Epine CEO, following the death of the company's former CEO, Bernard Massiot, in May 2011. Dr L'Epine will take up his position at the end of November, and has previously held general management roles at Novartis, Takeda and Abbott.